• In recent weeks, Dolby Laboratories Inc. and Hisense Co. Ltd. rolled out Dolby Vision 2 across select Hisense 2026 TV models via firmware updates, with platforms such as CANAL+, iQIYI, and Peacock committing to use its expanded capabilities.
• Alongside this, Dolby’s acquisition of a large Versatile Video Coding-focused video-compression IP portfolio signals a broader push to control more of the video technology stack behind future streaming experiences.
• Next, we will examine how Dolby Vision 2’s deeper integration with Hisense TVs could influence Dolby’s wider investment narrative and outlook.

We've uncovered the 9 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.

Dolby Laboratories Investment Narrative Recap

To own Dolby, you need to believe that premium audio and video standards like Atmos and Vision will stay embedded across TVs, streaming, and eventually cars, even as cheaper or royalty‑free options compete. The Hisense rollout of Dolby Vision 2 and the new VVC IP portfolio both speak directly to that thesis, but they do not remove the near term risk that commoditization in TVs and set‑top boxes could pressure licensing revenue and unit shipments.

Among recent announcements, Dolby’s updated full year 2026 guidance of US$1.41 billion to US$1.44 billion in revenue and GAAP EPS of US$2.62 to US$2.77 is especially relevant. It gives a reference point for how much Dolby is currently expecting to earn from its ecosystem, just as Vision 2 begins ramping across Hisense’s 2026 TV lineup and streaming partners start tapping its new capabilities.

Yet behind Dolby Vision 2’s promise, investors should be aware that growing competition from lower cost or royalty free codecs could...

Dolby Laboratories’ narrative projects $1.6 billion revenue and $366.3 million earnings by 2029. This requires 4.9% yearly revenue growth and about a $122.7 million earnings increase from $243.6 million today.

Uncover how Dolby Laboratories' forecasts yield a $78.33 fair value, a 28% upside to its current price.

Exploring Other Perspectives

While Dolby Vision 2 highlights ecosystem strength, the most pessimistic analysts still assume revenue of only about US$1.6 billion by 2029 and warn that heavy reliance on streaming and device partners could be challenged if proprietary or open alternatives spread faster than expected.

Explore 6 other fair value estimates on Dolby Laboratories - why the stock might be worth over 3x more than the current price!

Form Your Own Verdict

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your Dolby Laboratories research is our analysis highlighting 4 key rewards and 1 important warning sign that could impact your investment decision.
• Our free Dolby Laboratories research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Dolby Laboratories' overall financial health at a glance.

Want Some Alternatives?

Don't miss your shot at the next 10-bagger. Our latest stock picks just dropped:

• Uncover the next big thing with 19 elite penny stocks that balance risk and reward.
• Invest in the nuclear renaissance through our list of 90 elite nuclear energy infrastructure plays powering the global AI revolution.
• The future of work is here. Discover the 39 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.